M67.26
Synovial hypertrophy, not elsewhere classified, lower leg
Clinical Classification Guidelines
Medical Intelligence & Overview
Synovial hypertrophy refers to the abnormal thickening of the synovial membrane, which lines the joints. When this condition affects the lower leg, particularly around the ankle or knee, it can cause discomfort and impact mobility. This condition is classified under the ICD-10 code M67.26 and is known for its subtle symptoms that may go unnoticed until they become problematic. Recognizing the signs and understanding potential causes is essential for managing the condition effectively and preventing further joint complications.
Causes & Symptoms
Clinical Causes: Chronic joint inflammation due to conditions like osteoarthritis or rheumatoid arthritis Repetitive joint injury or overuse, especially in athletes or individuals engaged in physical labor Post-traumatic changes following an injury such as sprains, fractures, or ligament tears Degenerative joint diseases that lead to thickening of the synovial membrane over time Infections within the joint, although less common, can also lead to synovial hypertrophy Autoimmune responses that result in inflammation and subsequent tissue proliferation
Key Symptoms: Swelling around the affected joint, often localized and gradual in onset Visible or palpable thickening of the synovial membrane, feeling like a lump or bump Joint stiffness, especially after periods of inactivity or in the mornings Discomfort or mild pain during joint movement Reduced range of motion or stiffness that may limit daily activities Occasional warmth or tenderness around the affected joint during flare-ups
Diagnostic & Treatment
Diagnosis Path: Diagnosing synovial hypertrophy involves a clinical examination by a healthcare professional, which includes assessing the joint for swelling, tenderness, and range of motion. Imaging studies are crucial for confirming the diagnosis and understanding the extent of thickening:
Treatment Protocols: Management of synovial hypertrophy aims to reduce inflammation, alleviate symptoms, and maintain joint function. Treatment strategies are tailored to the severity of the condition and the underlying cause:
Clinical Advice & FAQs
Billing Guidance
Is M67.26 a billable ICD-10 code?
Yes, M67.26 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M67.26?
Clinical documentation must specify the nature of Synovial hypertrophy, not elsewhere classified, lower leg and any associated comorbidities for accurate reporting.
Cite this Clinical Reference